SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-037685
Filing Date
2024-08-19
Accepted
2024-08-19 16:06:34
Documents
15
Period of Report
2024-08-19
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dna-20240819.htm   iXBRL 8-K 29849
2 EX-3.1 ex31.htm EX-3.1 121341
  Complete submission text file 0001628280-24-037685.txt   346775

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20240819.xsd EX-101.SCH 2315
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20240819_def.xml EX-101.DEF 16478
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20240819_lab.xml EX-101.LAB 29228
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20240819_pre.xml EX-101.PRE 17276
18 EXTRACTED XBRL INSTANCE DOCUMENT dna-20240819_htm.xml XML 4549
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 241220461
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)